Skip to main content
SpringerLink
Log in

Rezidivierende Clostridium-difficile-Infektion

Therapie mit duodenaler Infusion von Spenderfäzes

Recurrent Clostridium difficile infection

Treatment with duodenal infusion of donor feces

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Borody TJ, Khoruts A (2012) Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9:88–96

    Article  CAS  Google Scholar 

  2. Brandt LJ, Aroniadis OC, Mellow M et al (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107:1079–1087

    Article  PubMed  Google Scholar 

  3. Eiseman B, Silen W, Bascom GS, Kauvar AJ (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44:854–859

    PubMed  CAS  Google Scholar 

  4. Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994–1002

    Article  PubMed  Google Scholar 

  5. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A (2012) Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107:761–767

    Article  PubMed  Google Scholar 

  6. Kamada N, Seo SU, Chen GY, Nunez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321–335

    Article  PubMed  CAS  Google Scholar 

  7. Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108:500–508

    Article  PubMed  Google Scholar 

  8. Kleger A, Schnell J, Essig A et al (2013) Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int 110:108–115

    PubMed Central  PubMed  Google Scholar 

  9. Kump PK, Gröchenig HP, Hoffmann CM et al (2012) Fäkale Bakterientherapie (Stuhltransplantation) bei therapierefraktärer Colitis ulcerosa – eine Pilotstudie. Z Gastroenterol 50:P26

    Google Scholar 

  10. Louie TJ, Miller MA, Mullane KM et al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422–431

    Google Scholar 

  11. Lowy I, Molrine DC, Leav BA et al (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 362:197–205

    Google Scholar 

  12. Postigo R, Kim JH (2012) Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 40:643–648

    Article  PubMed  CAS  Google Scholar 

  13. Shahinas D, Silverman M, Sittler T et al (2012) Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 3:e00338–12. DOI 10.1128/mBio.00338-12

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Smith PM, Howitt MR, Panikov N et al (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569–573

    Article  PubMed  CAS  Google Scholar 

  15. Stepan C, Surawicz CM (2007) Treatment strategies for C. difficile associated diarrhea. Acta Gastroenterol Latinoam 37:183–191

    PubMed  Google Scholar 

  16. Surawicz CM, Alexander J (2011) Treatment of refractory and recurrent Clostridium difficile infection. Nat Rev Gastroenterol Hepatol 8:330–339

    Article  PubMed  CAS  Google Scholar 

  17. Vrieze A, Van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:913–916.e7

    Article  PubMed  CAS  Google Scholar 

  18. Zhang F, Luo W, Shi Y et al (2012) Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 107:1755 (Autorenantwort: 1755–1756)

    Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. T. Seufferlein, A. Kleger und S. Nitschmann geben an, dass kein Interessenkonflikt besteht. Der Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin I, Zentrum für Innere Medizin, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland

    T. Seufferlein &  A. Kleger

  2. -, Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. T. Seufferlein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Kleger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Kleger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seufferlein, T., Kleger, A. & Nitschmann, S. Rezidivierende Clostridium-difficile-Infektion. Internist 55, 455–459 (2014). https://doi.org/10.1007/s00108-014-3483-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-014-3483-0

Search

Navigation